Study is Australia’s most complete thus far within the medicinal hashish sector, recruiting 20,000 sufferers nationwide

SYDNEY, NSW, AUSTRALIA, October 25, 2020 / — Applied Cannabis Research (ACR), a Southern Cannabis Holdings firm, is extraordinarily excited to announce that it’s launching Australia’s largest observational research ever undertaken for medical hashish. ACR will lead the research at the side of Australia’s medical neighborhood and key business companions equivalent to Althea Group Holdings, Cronos Australia, Cymra Life Sciences, Medcan Australia and Cann Global.

Working with scientific collaborators from main clinics and hospitals, the Cannabinoid Medicine Observational Study (CMOS) will accumulate knowledge from 20,000 sufferers nationwide to evaluate the protection and efficacy of medicinal hashish merchandise for a spread of refractory circumstances together with fibromyalgia, continual ache syndromes, PTSD,…

Original Author Link click here to read complete story..

Source link